title: Extracorporeal membrane oxygenation for perioperative support in neonatal and pediatric cardiac transplantation.
abstract: Currently there is a lack of consensus on guidelines in the clinical application of extracorporeal membrane oxygenation (ECMO) in neonatal and pediatric cardiac transplantation patients. In this context, given the limited data presently available through the Extracorporeal Life Support Organization (ELSO) Registry, we conducted a preliminary survey to specifically evaluate the practice of using ECMO as a bridge to cardiac transplantation or as posttransplantation therapy for failure to wean from cardiopulmonary bypass or graft failure. We received responses to our questionnaire from 95 of 118 (81%) centers located in the U.S.A. and abroad. Of the 95 centers that responded, 36 were performing neonatal/pediatric cardiac transplants, with 29 centers reporting the concomitant use of ECMO to support cardiac transplant patients. There was wide variability in the responses from the 29 centers to a selected list of relative ECMO contraindications. However, only 7 centers had specific ECMO entry criteria for cardiac transplant patients. Fifteen of the 29 centers provided relevant data on cardiac transplant patients including the proportions of neonatal (11 of 37) and pediatric (63 of 217) patients requiring ECMO; neonatal (2 of 5) and pediatric (16 of 27) patients surviving to transplant; and neonatal (1 of 5) and pediatric (12 of 27) patients surviving to hospital discharge. These findings confirm the important role of ECMO in providing perioperative support in neonatal and pediatric cardiac transplantation patients. However, the lack of consensus among centers contributes to uncertainty in the decision making process to offer ECMO and to utilize ECMO effectively in this high risk population. We recommend that institution-specific information be collected, either using the ELSO Registry (or by a similar multicentric database) to develop specific guidelines for ECMO applications in cardiac transplant patients, and to carefully monitor and follow up EMCO treated patients to further evaluate the efficacy of this limited resource.
authors.affiliation: Division of Neonatology, Department of Pediatrics, Loma Linda University School of Medicine, California 92354, USA.
authors.forename: A O
authors.initials: AO
authors.lastname: Hopper
authors.forename: J
authors.initials: J
authors.lastname: Pageau
authors.forename: L
authors.initials: L
authors.lastname: Job
authors.forename: J
authors.initials: J
authors.lastname: Heart
authors.forename: D D
authors.initials: DD
authors.lastname: Deming
authors.forename: R L
authors.initials: RL
authors.lastname: Peverini
mesh_terms: D002315:Cardiopulmonary Bypass; D000075202:Contraindications; D019992:Databases as Topic; D003657:Decision Making; D005069:Evaluation Studies as Topic; D015199:Extracorporeal Membrane Oxygenation / Q000706:statistics & numerical data; D005500:Follow-Up Studies; D006085:Graft Survival; D016027:Heart Transplantation; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008991:Monitoring, Physiologic; D010351:Patient Discharge / Q000706:statistics & numerical data; D019990:Perioperative Care; D017410:Practice Guidelines as Topic; D012042:Registries; D012307:Risk Factors; D011795:Surveys and Questionnaires; D015996:Survival Rate